Gregory Tall About Dr. Gregory Tall " Dr. Gregory Tall earned his Ph.D. in Biomedical Sciences from U.T. Gregory Tall on the web The Tall Lab University of Michigan Google Scholar Twitter Dr.

Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter

For Agrawal it is personal: he spent his PhD on four GPCRs and now stewards 289, carrying those early About the Guests Jane Lamerdin is VP of R&D at Eurofins DiscoverX, where she oversees development of

what was structurally possible, how cryoEM then redrew the map again, and what the first solved Class D funding, and growth CryoEM and the conformational states that crystallography could never access Class D A Class D GPCR dimer with no prior blueprint The first solved structure of a Class D GPCR - a yeast receptor why the arrestin-coupled structure could never have come from a crystal 45:17 Unpublished: a Class D of a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D

behind pH Sense, Revvity’s innovative GPCR internalization assay, and his journey in GPCR product R&D. Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical

These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific

discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D

In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.

His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs

Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&D and managing a focused development team, pursued international strategic partnerships, managed IP

I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart

Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&D

I have 10 years of experience in the development and management of R&D projects and teams in the field Sciences from the University of Lausanne, Switzerland, Department of Biochemistry (2005-2009), where I started And since then, my incredible adventure as CEO of this fast-growing company started and is continuing

to the GPCR field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D

He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder

Revvity, Eric worked for Cisbio Bioassays first as Director of Technological Development and then as R&D Elodie DUPUIS R&D Senior project manager, team leader.

chemists and structural biologists Early-career researchers exploring drug discovery Biotech leaders and R&D

My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed me to shape a swiss start-up company from a scientifc idea to a thriving Biotech focusing on Systems

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in

Yamina Berchiche on the web D r.

A pharmacologist by training, she spent more than six years in early R&D at Novo Nordisk before turning

sampling approaches for membrane proteins in collaborations with Thomas Huber , Xavier Periole , and Siewert-Jan

Report inappropriate use of a D. GPCR trademark. Buttons And Badges The Dr.

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook